Doaa EL Demerdash: Connecting the Global ITP Community at ISTH 2026
Doaa EL Demerdash, Professor at Cairo University and Hematology Consultant at Cleopatra Hospitals Group, shared a post on LinkedIn:
”It was a great pleasure to attend ISTH 2026
And it was a great opportunity to catch recent advances in T&H my main focus and meet colleagues from all over the world shared thoughts and different experiences and also a great chance to meet my role models in hematology prof kuter from USA, Waleed Ghanima MD, Ph.D. From Norway and prof Hanny Al-Samkari from USA
And keep reminding to share in our international survey about managing ITP in lower and middle countries as up till now representive physicians from 66 countries are sharing and we still missing contributions from some low and middle income countries.
This is an international survey for ITP Immune thrombocytopenia
And I hope physicians managing ITP (adult and pediatrics) to share their valuable experience in this international ITP survey (as participation from African countries unfortunately are missing).
It will take few minutes to be completed
Kindly need your kind and valuable support.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development
-
Oct 20, 2026, 03:13Sumyea Kabir: Pre-Analytical Quality in Phlebotomy – Preventing In Vitro Hemolysis
-
Oct 20, 2026, 02:37M. Sekip Altunkan: Can Anticoagulation Be Safely Stopped After AF Ablation?
-
Oct 20, 2026, 02:26Ahmed Ammar: Managing VT Recurrence Post-Ablation
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation